Metabolic disorder | Unadjusted OR (95% CI) | Adjusted model 1a OR (95% CI) | Adjusted model 2b OR (95% CI) | Adjusted model 3c OR (95% CI) |
---|---|---|---|---|
Men | Â | Â | Â | Â |
   Abdominal obesity | 0.81 (0.53–1.24) | 0.85 (0.52–1.37) | 0.80 (0.49–1.32) | 1.07 (0.65–1.76) |
   Hypertriglyceridemia | 0.79 (0.55–1.14) | 0.86 (0.58–1.30) | 0.85 (0.53–1.36) | 0.92 (0.54–1.56) |
   Low HDL cholesterol | 0.99 (0.69–1.43) | 0.98 (0.67–1.45) | 1.05 (0.65–1.72) | 0.83 (0.54–1.28) |
   High blood pressure or medication use | 1.69 (1.08–2.64) | 1.24 (0.76–2.03) | 1.28 (0.77–2.13) | 1.11 (0.65–1.89) |
   High fasting glucose or medication use | 1.31 (0.91–1.89) | 1.13 (0.75–1.70) | 1.19 (0.79–1.79) | 1.14 (0.73–1.76) |
   Metabolic syndrome | 1.15 (0.80–1.65) | 1.10 (0.73–1.66) | N/A | 1.15 (0.76–1.74)d |
Women | Â | Â | Â | Â |
   Abdominal obesity | 0.87 (0.53–1.44) | 0.72 (0.42–1.21) | 0.48 (0.26–0.89) | 0.37 (0.18–0.76) |
   Hypertriglyceridemia | 1.09 (0.70–1.71) | 0.96 (0.57–1.59) | 0.68 (0.36–1.30) | 0.59 (0.31–1.10) |
   Low HDL cholesterol | 1.65 (0.98–2.77) | 1.88 (1.04–3.41) | 2.26 (1.08–4.75) | 2.45 (1.07–5.63) |
   High blood pressure or medication use | 2.57 (1.22–5.39) | 1.30 (0.61–2.77) | 1.33 (0.61–2.92) | 1.00 (0.45–2.22) |
   High fasting glucose or medication use | 2.42 (1.60–3.68) | 1.90 (1.14–3.17) | 2.05 (1.12–3.74) | 1.84 (0.84–4.03) |
   Metabolic syndrome | 1.41 (0.91–2.17) | 1.20 (0.75–1.91) | N/A | 0.89 (0.51–1.53)d |